Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group-Reference-Cited by-同舟云学术

Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group

Published:2021-12 Issue:6 Volume:51 Page:1378-1385
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Morillon Melanie Birger,Christensen Robin,Singh Jasvinder A.,Dalbeth Nicola,Saag Kenneth,Taylor William J.,Neogi Tuhina,Kennedy Martin A.,Pedersen Birthe M.,McCarthy Geraldine M.,Shea Beverley,Diaz-Torne Cesar,Tedeschi Sara K.,Grainger Rebecca,Abhishek Abhishek,Gaffo Angelo,Nielsen Sabrina Mai,Noerup Alexander,Simon Lee S.,Lassere Marissa,Tugwell Peter,Stamp Lisa K.,Gout Working Group for the OMERACT

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference26 articles.

1. Febuxostat compared with allopurinol in patients with hyperuricaemia and gout;Becker;N Engl J Med,2005

2. An open-label, 6-month study of allopurinol safety in gout: The LASSO study;Becker;Semin Arthritis Rheum,2015

3. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials;Sundy;JAMA,2011

4. Lesinurad Combined With Allopurinol: Randomized, Double-Blind, Placebo-Controlled Study in Gout Subjects With Inadequate Response to Standard of Care Allopurinol (A US-based Study);Saag;Arthritis Rheum,2017

5. of ftCGC, Physicians tACo. Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians;Qaseem;Ann Int Med,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on serum urate‐lowering efficacy and safety of Tigulixostat in gout patients with hyperuricemia: A randomized, double‐blind, placebo‐controlled, dose‐finding trial;International Journal of Rheumatic Diseases;2024-01

2. Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial;Arthritis & Rheumatology;2023-04-26

3. Critical appraisal of serum urate targets in the management of gout;Nature Reviews Rheumatology;2022-08-16

4. When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy;Nature Reviews Rheumatology;2022-07-25